Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 08 tags : Cancer save search
Surface Oncology Presents New SRF388 Data at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 21:00) - globenewswire.com
SURF | $1.07 -0.93% -1.41% 0
|
Health Technology
| Email alert
Add to watchlist
srf388 research cancer
Plus Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 21:00) - globenewswire.com
PSTV | News | $1.55 -4.91% 4.9K
|
Health Technology
| Email alert
Add to watchlist
research therapeutics presentation cancer
Cellectis Presents Preclinical Data from its First Allogeneic Dual CAR T-cell Product Candidate UCART20x22 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Published: 2022-04-08 (Crawled : 21:00) - globenewswire.com
CLLS | News | $2.53 -3.42% 25K
|
Health Technology
| Email alert
Add to watchlist
ucart20 research preclinical t-cell cancer pre-clinical
Shattuck Labs Presents Preclinical Data at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 21:00) - globenewswire.com
STTK | $9.85 3.79% 130K
|
Health Technology
| Email alert
Add to watchlist
research preclinical cancer pre-clinical
Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
CRBP | $34.995 -7.27% 130K
|
Health Technology
|
| O: 1.8%
H: 5.02%
C: -6.93%
crb-601 research preclinical cancer pre-clinical
Theseus Pharmaceuticals Announces Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
THRX | $4.06 0.49% 0
|
|
| O: -0.79%
H: 1.91%
C: -0.72%
research preclinical cancer growth pre-clinical
Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
BPMC | $92.51 0.24% 160K
|
Health Technology
|
| O: 0.94%
H: 3.74%
C: 0.86%
AZN | News | $71.26 0.58% 3.8M
|
Health Technology
|
| O: -0.55%
H: 1.53%
C: 0.74%
blu-945 cancer
Arcellx Presents Pre-Clinical Data for ACLX-002, a Novel CD123-targeted Universal CAR-T Cell Therapy for Relapsed or Refractory Acute Myeloid Leukemia at the American Association for Cancer Research Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
ACLX | $53.84 -1.1% 100K
|
|
| O: -0.31%
H: 1.15%
C: -0.54%
aclx-002 research pre-clinical car-t leukemia therapy cancer preclinical acute myeloid leukemia
Cardiff Oncology Announces Updated Clinical and New Biomarker Data from Phase 2 Metastatic Castration-Resistant Prostate Cancer Trial at the AACR Annual Meeting
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
CRDF | $4.25 1.92% 190K
|
Health Services
|
| O: -0.84%
H: 4.68%
C: -1.7%
trial cancer biomarkers phase 2 prostate cancer
Syros Presents New Preclinical Data on its CDK12 Inhibitor Program at American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 19:00) - biospace.com/
SYRS | $5.135 -0.1% 34K
|
Health Technology
|
| O: 0.0%
H: 10.28%
C: 7.48%
cdk12 research preclinical program cancer pre-clinical
Kymera Therapeutics Presents Preclinical Data Highlighting Biological Superiority of MDM2 Degradation over Inhibition and Shares Profile of Clinical Candidate KT-253 at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
KYMR | $35.1 -1.71% 120K
|
Health Technology
|
| O: 0.0%
H: 0.61%
C: -4.78%
kt-253 research preclinical therapeutics cancer pre-clinical
X4 Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
XFOR | $1.26 2.44% 930K
|
Health Technology
|
| O: -1.65%
H: 1.68%
C: -2.23%
research cancer
PathAI Announces Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
SNY | News | $46.615 -2.25% 730K
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
research cancer
Nykode Therapeutics announces presentation of preclinical data from its second generation Vaccibody vaccine technology at 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
NKTR | News | $1.405 -1.06% 290K
|
Health Technology
|
| O: 0.17%
H: 1.21%
C: -4.67%
research preclinical vaccine technology therapeutics presentation cancer pre-clinical
MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
MEIP | $3.395 1.88% 3.7K
|
Health Technology
|
| O: -0.82%
H: 1.43%
C: -0.88%
pharma research cancer
Theratechnologies Presents New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
THTX | $1.29 -12.78% 8.1K
|
Health Technology
|
| O: 3.4%
H: 0.0%
C: -1.23%
th1902 preclinical cancer growth pre-clinical ovarian cancer
Cardiff Oncology Announces Data Showing the Combination of PARP Inhibition with Onvansertib Overcomes PARP Inhibitor Resistance in BRCA1-mutant and Wildtype Patient-Derived Xenograft Ovarian Cancer Models
Published: 2022-04-08 (Crawled : 18:00) - prnewswire.com
CRDF | $4.25 1.92% 190K
|
Health Services
|
| O: -0.84%
H: 4.68%
C: -1.7%
onvansertib cancer ovarian cancer
Xencor Presents Data from Multiple Preclinical XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - biospace.com/
XNCR | $18.55 0.98% 180K
|
Health Technology
|
| O: -0.6%
H: 0.46%
C: -2.39%
xmab research preclinical cancer pre-clinical
Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T (PYX-106) Presented by Biosion, Inc. at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
PYXS | $4.49 -0.22% 120K
|
Professional, Scientific, and T...
|
| O: -3.2%
H: 9.63%
C: 3.31%
bsi-060 research preclinical cancer pre-clinical
Vincerx Pharma Presents Preclinical and Preliminary Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Gynecologic Malignancies at the American Association for Cancer Research (AACR) Annual Meeting 2022
Published: 2022-04-08 (Crawled : 18:00) - globenewswire.com
VINC | $0.922 -2.95% 300K
|
|
| O: -0.52%
H: 1.64%
C: -5.26%
vip152 pharma research preclinical cancer pre-clinical
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.